Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2026

Sunrise Realty Trust, Inc. (Nasdaq: SUNS) reported Q2 2026 results for the quarter ended June 30, 2026. GAAP net income was $3.1 million, or $0.23 per share, and Distributable Earnings were $3.9 million, or $0.29 per share. The company paid a $0.30 per-share dividend on July 15, 2026, totaling $4.1 million.

Original reporting
Published Aug 6, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SUNS
Bullish
medium confidence
Mentioned
$SUNS
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$SUNSBullishMed
01

Why it matters

The company’s Q2 2026 results, dividend payment, and liquidity commentary (Panther National repayment) provide fresh information for traders assessing near-term income coverage and credit risk in transitional CRE lending.

02

Market read

Traders can update positions based on the reported quarterly earnings and dividend coverage, plus the stated post-quarter repayment and expectations for demand under constrained senior debt capacity.

03

What to watch

The release emphasizes loans being current but does not quantify credit metrics, leverage changes, or portfolio composition in the provided excerpt, which could limit conviction on forward earnings power.

Relevance 7/10Novelty 7/10Timing: today’s earnings release and conference call (Aug 6, 2026)

Background

Sunrise Realty Trust is a Nasdaq-listed commercial real estate lender focused on transitional financing on a platform associated with Tannenbaum Capital Group.

Company-level read

Ticker impact

$SUNSBullishMedium confidence
Context

Sunrise Realty Trust reported Q2 2026 GAAP net income of $3.1M and Distributable Earnings of $3.9M, plus a $0.30/share dividend.

Expected impact

Moderate upside bias if investors view Distributable Earnings as sustaining the dividend and the Panther National repayment as de-risking near-term deployment.

Evidence & confidence

The article provides concrete quarterly earnings, per-share figures, dividend payment details, and a specific liquidity event (Panther National repayment) plus forward-looking demand commentary tied to elevated rates.

Market effects

Adds another data point on transitional CRE lending performance and dividend sustainability for mortgage/CRE REIT-style lenders amid elevated rates.

Highlights Southern U.S. CRE lending demand and credit performance, which can influence sentiment toward regional CRE credit risk.

Limited direct global linkage; primarily affects U.S. CRE credit and REIT income narratives.

Counterpoint

Distributable Earnings outpacing dividends may be helped by timing and one-off items, so the market may discount durability if credit losses or loan rollovers worsen later.

Key entities

  • Sunrise Realty Trust, Inc.

    Subject of the earnings release; reported Q2 2026 GAAP net income, Distributable Earnings, and paid a $0.30/share dividend.

  • Panther National

    Investment was fully repaid shortly after quarter end, cited as reinforcing origination and exit capability.

  • Tannenbaum Capital Group (TCG) Real Estate platform

    Describes the broader real estate debt fund platform that includes SUNS.

Related articles

$SUNSMed

Sunrise Realty Trust, Inc. (SUNS): Results of Operations and Financial Condition

Sunrise Realty Trust, Inc. (SUNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sunsearningsreleaseq22026e.htm EX-99.1 Document Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net income of $3.1 million or $0.23 per basic weighted average common share and Distributable Earnings ( 1 ) of $3

$LLYMedAI 8/10

Lilly Highlights Sleep Apnea Drug Progress and Sleep-Wake Disorder Acquisition in Q2 Report

Eli Lilly reported Q2 2026 results, saying worldwide revenue rose 48% to $23.0B, driven by volume growth led by Mounjaro and Zepbound, and raised full-year revenue guidance to $85B-$87B. In pipeline updates, the company said its triple agonist retatrutide improved obstructive sleep apnea in trials. Lilly also completed its acquisition of Centessa Pharmaceuticals to advance sleep-wake disorder treatments.

$QTIMedAI 8/10

QT Imaging (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

$FENCMed

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals (NASDAQ:FENC) reported Q2 results on an earnings call. Net product sales were $17.1 million, up 78% year over year. Non-GAAP adjusted EBITDA was $2.8 million versus a $1.2 million loss a year earlier. Cash and cash equivalents were $41.2 million at June 30, 2026. Management cited PEDMARK momentum and no quantitative 2026 revenue outlook.

$MIDDMedAI 8/10

Middleby Q2 Earnings Call Highlights

Middleby (NASDAQ:MIDD) said dealer-channel growth remains positive but should moderate in H2, with Q3 and Q4 growth driven mainly by chain customers. Q2 organic adjusted EBITDA margin was 25.8%, below expectations due to mix, inflation and ice and beverage investments. Q2 adjusted EBITDA was ~$193M and adjusted EPS $2.35. Full-year organic growth outlook raised to 6% to 8%.

$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.